 |
(Natural News) An analysis published in the journal Endocrine Reviews, the flagship publication of the Endocrine Society, revealed that the contraceptive injection depot-medroxyprogesterone acetate (DMPA) may increase the risk of contracting human immunodeficiency virus (HIV) among women from sub-Saharan Africa and other high-risk regions. A team of researchers at the University of Cape Town in South Africa and the University of Alabama at… |
>View original article
Author: